Innovations in allogeneic stem-cell transplantation

Seminars in Hematology

Volumn 37, Issue 1 SUPPL. 2, 2000, Pages 33-41

  DiPersio, John F ^a   Khoury, Hanna ^a   Haug, Jeff ^a   Vij, Ravi ^a   Adkins, Douglas R ^a   Goodnough, L Tim ^a   Brown, Randy A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; APHERESIS; ARTICLE; BLEEDING; CELL KINETICS; CELL MIGRATION; CLINICAL TRIAL; ERYTHROCYTE TRANSFUSION; FEVER; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION; MAJOR CLINICAL STUDY; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0034060563     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90087-8     Document Type: Article

References (26)

1. DR Adkins G Spitzer M Johnson Transfusions of granulocyte-colony-stimulating factor mobilized granulocyte components to allogeneic transplant recipients: Analysis of the kinetics and factors determining post-transfusion neutrophil and platelet counts Transfusion 37 1997 737 748
2. WI Bensinger CD Buckner K Shannon-Dorcy Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy Blood 88 1996 4132 4138
3. WI Bensinger CH Weaver FR Appelbaum Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor Blood 85 1995 1655 1658
4. F Bertolini M Battaglia P Pedrazzoli Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients Blood 89 1997 2679 2688
5. RA Brown D Adkins J DiPersio Allogeneic peripheral blood stem cell transplantation (PBSC) is associated with an increased risk of chronic graft-vs-host disease Blood 90 suppl 1 1997 225a abstr
6. RA Brown D Adkins LT Goodnough Factors that influence the collection and engraftment of allogeneic peripheral-blood stem cells in patients with hematologic malignancies J Clin Oncol 15 1997 3067 3074
7. RA Brown D Adkins H Khoury Long term follow up of allogeneic peripheral blood stem cell transplant recipients: Graft-vs-host disease and transplant related mortality J Clin Oncol 17 1999 806 812
8. + progenitor cells from matched related donors Bone Marrow Transplant 18 1996 1081 1086
9. DN Haylock LB To TL Dowse Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage Blood 80 1992 1405 1412
10. CA Juttner LB To JQ Ho Early lympho-hematopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia Transplant Proc 20 1988 40 42
11. A Kessinger JO Armitage JD Landmark Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy Blood 3 1988 723 727
12. A Kessinger JO Armitage DM Smith High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma Blood 4 1989 1260 1265
13. HG Klein TH Price RG Strauss Granulocyte transfusion redux Education Program, presented at the American Society of Hematology meeting San Diego, CA 1997 138 145
14. M Körbling D Ptzepiorka YO Huh Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts Blood 85 1995 1659 1665
15. D Kuter J McCullough J Romo Treatment of platelet (PLT) donors with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) increases circulating PLT counts and PLT apheresis yields and increases platelet increments in recipients of PLT transfusions Blood 90 suppl 1 1997 579a abstr
16. + blood cells Blood 87 1996 4903 4909
17. A Rambaldi P Viero R Bassan G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation of resistant or relapsing acute leukemias Leukemia 10 1996 860 865
18. J Reiffers S Castaigne H Tilly Hematopoietic reconstitution after autologous blood stem cell transplantation: a report of 46 cases Plasma Ther Transfus Technol 8 1987 360 362
19. RA Roscoe WB Rybka A Winkelstein Enumeration of CD34 hematopoietic stem cells for reconstitution following myeloablative therapy Cytometry 16 1994 74 79
20. C Rosenfeld R Collins L Pineiro Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: A phase II study J Clin Oncol 14 1996 1314 1319
21. N Schmitz P Dreger M Suttorp Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood 85 1995 1666 1672
22. N Schmitz DC Linch P Dreger Randomized trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients Lancet 347 1996 353 357
23. S Shenoy T Mohanakumar G Todd Immune reconstitution following allogenic peripheral blood stem cell transplants Bone Marrow Transplant 23 1999 335 346
24. SL Smith JG Bender PB Maples Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow Exp Hematol 21 1993 870 877
25. R Vij RA Brown D Adkins Mobilization of normal donors with G-CSF and GM-CSF is associated with improved yield of progenitors and increased numbers of activated dendritic cells Blood 90 suppl 1 1998 682a abstr
26. + cells in autologous stem cell transplantation for breast cancer Blood 87 1996 1687 1691